Utrecht Region. At the heart of the Netherlands Life Sciences and Health industry. Why locate your life sciences company in the Utrecht Region?

Similar documents
Utrecht Region. A key role in the Netherlands medical technology industry. Why locate your medical technology company in the Utrecht Region?

Utrecht Region continues to lead Europe s most competitive regions

PROGRAM ANNOUNCEMENT. New Jersey Institute of Technology. MSPhM Systems Engineering. Newark. Fall 2008

Surrey Knowledge Transfer Account

MCGILL CENTRE FOR THE CONVERGENCE OF HEALTH AND ECONOMICS (MCCHE)

Scripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011

Connecting Science and Society. NWO strategy

Powered by: Norway for Life Science. Photo cover: Christopher Olssøn Design: Fete typer

Innovative Business Incubation Foster the Growth of Technology

NEWS RELEASE. Life sciences companies tout their expertise in India

Research Development Request - Profile Template. European Commission

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

The Biological and Medical Sciences Research Infrastructures on the ESFRI Roadmap

GREATER MONTRÉAL Life Sciences & Health Tech hub

The Dutch National Research Agenda

Netherlands Organisation for Scientific Research (NWO) of science

Health & Social Care Industrial Innovation

Health Innovations in Horizon 2020: the framework programme for research and innovation ( )

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Technology and Innovation in the NHS Highlands and Islands Enterprise

The Netherlands Life Sciences Gateway to Europe

JURY BOARD BUSINESS/INVESTMENT. Pascal BECACHE Founding President, PBS, Healthcare Industry STRATEGY/BUSINESS

THE NUMBERS OPENING SEPTEMBER BE PART OF IT

Strategic Planning Framework

Kate Pretty Lecture Thursday 8 March Pascal Soriot, CEO AstraZeneca. What Science Can Do The Cambridge Cluster at a Pivot Point

Fifth Framework Programme for Research, Technological Development and Demonstration Quality of Life and Management of Living Resources

Commission on science and Technology for Development. Ninth Session Geneva, May2006

Infrastructure, International

Agenda. Genesys Capital Partners. The Opportunity. Our Approach

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

9 Vaccine SMEs' Needs

Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter

TAB V. VISION 2030: Distinction, Access and Excellence

Industry Academia Government alliance

Speakers biography. Gita Krishnankutty Head of Inward Investment India

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Digital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver

Learning Lessons Abroad on Funding Research and Innovation. 29 April 2016

Applied Research APPLIED KNOWLEDGE INNOVATIVE RESEARCH PROVEN RESULTS. nscc.ca/appliedresearch

NIHR ROADSHOW FOR MEDTECH SMES

Biocommercialization: Providing Enabling Policy Environments

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

THE BIOMEDICAL ENGINEERING TEACHING & INNOVATION CENTER. at Boston University s College of Engineering

Nano4Health. February 14 th Lieve Apers Coordinator Nano4Health

SASKATCHEWAN INSTITUTE MAY Ready, Set, Grow.

TWENTE REGION. Green Knowledge Portal Twente

Written response to the public consultation on the European Commission Green Paper: From

CASI Pharmaceuticals, Inc.

TRANSLATIONAL SCIENCE

Medicines Manufacturing in the UK 2017

Marie Skłodowska- Curie Actions under Horizon2020

ACCESS TO FINANCING FOR SMEs Problems and Challenges. Prof. dr Dejan Erić Belgrade Banking Academy Member of the ERENET Network 2005.

Education and Culture

Project: HELIUM - Health Innovation Experimental Landscape through Policy Improvement -

MANUFACTURING INSTITUTE

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

Omeros Raises More Than $63 Million in Financing

High Tech Industry in Georgia

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

Conclusions on the future of information and communication technologies research, innovation and infrastructures

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D

Implementation of Systems Medicine across Europe

Enabling ICT for. development

Industrial Strategy Green Paper Response from The Institute of Cancer Research, London

KIC EIT Raw Materials

Wolfpack Investor Network. Investing in Our University s Best and Brightest

Programme. Social Economy. in Västra Götaland Adopted on 19 June 2012 by the regional board, Region Västra Götaland

Commission proposal for Horizon Europe. #HorizonEU THE NEXT EU RESEARCH & INNOVATION PROGRAMME ( )

The Investigation of Bio-medical Science and Technology Innovation Service Platform in Guangzhou

Magnus Steigedal Director NTNU Health NTNU

THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES

Research Strategy of Tampere University Community

Dynamic Cities and Creative Clusters

2010/3 Science and technology for development. The Economic and Social Council,

The New Delhi Communiqué

Singapore delegation visiting Dutch Smart Industry and Robotics ecosystem

Koen Dejonckheere. Professional experience. Board Memberships. Education

Please send your responses by to: This consultation closes on Friday, 8 April 2016.

Canada s National Design Network. Community Research Innovation Opportunity

An Introduction to China s Science and Technology Policy

Table of Contents News release: Strong job growth thanks to foreign direct investment in the Netherlands... 4 Infographic: Additional jobs in the

COUNCIL OF THE EUROPEAN UNION. Brussels, 9 December 2008 (16.12) (OR. fr) 16767/08 RECH 410 COMPET 550

Academic Program IIT Rajasthan

Reduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?

PURDUE SCHOOL OF ENGINEERING AND TECHNOLOGY AT IUPUI

Igor Fisch. New candidate, independent

Europe as a Global Actor. International Dimension of Horizon 2020 and Research Opportunities with Third Countries

DANUBE INNOVATION PARTNERSHIP

Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO

European Nuclear Education Network Association

Science, Research and Information Technology

Finding a partner in Norway. Aleksandra Witczak Haugstad, senior adviser Research Council of Norway

Hellenic Technology Clusters Initiative

Organ-on-chip Networking in Europe Joining forces for the future

PANEL DISCUSSION & ROUNDTABLES

FINLAND. The use of different types of policy instruments; and/or Attention or support given to particular S&T policy areas.

EU s Innovative Medical Technology and EMA s Measures

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in

Barcelona: European Innovation Capital? Friday 28th March 2008, London. FT GLOBAL CONFERENCES & EVENTS

Funding opportunities for BigSkyEarth projects. Darko Jevremović Brno, April

Transcription:

Utrecht Region At the heart of the Netherlands Life Sciences and Health industry Why locate your life sciences company in the Utrecht Region? Utrecht is at the heart of the Netherlands life sciences industry and is particularly strong in public health, one health, cancer research, regenerative medicine and stem cell technology. Research institutions in the region have joined forces to support the sustainable development goals of active ageing and long-term care. The One Health initiative for example is a crossdiscipline initiative involving Utrecht s universities, research institutes and private industry that aims to develop an integrated approach to finding long-term solutions for human and animal infectious diseases and antibiotic resistance. 1

Why the Netherlands? Home to the European Medicines Agency from 2019 The Netherlands central position in Western Europe, its excellent transport and internet infrastructure, and highly-skilled workforce, make it the ideal location for the 2,900 life sciences, medical technology and research organisations based here. The World Economic Forum ranks the Netherlands fourth in it s Global Competitiveness Report 2017-2018 mainly because of its stable business climate. And according to the Global Innovation Index 2017, the Netherlands ranks highly for its regulatory environment, infrastructure and creativity. The decision to relocate the European Medicines Agency to the Netherlands is a further boost to the fast-developing Life Sciences and Health industry. Making the most of regional advantages The Utrecht Region is smart, central and offers you a great quality of life. Utrecht Region is a center of knowledge Utrecht s world class scientific institutions include the Utrecht University, home to the only Faculty of Veterinary Medicine in the Netherlands and the UMC Utrecht as well as the HU University of Applied Sciences Utrecht. Research institutes in the region include the Princess Máxima Center for pediatric oncology, the National Institute for Public Health and the Environment (RIVM) and the KNAW Hubrecht Institute for developmental biology and stem cell research. Utrecht Region is centrally located Conveniently located in the heart of the Netherlands, Utrecht has excellent public transport and road links to the rest of the Netherlands and Europe and is just 30 minutes from Schiphol airport. Utrecht is also within very easy reach of Amsterdam (25 minutes) home of the European Medicines Agency from 2019. Utrecht Region has a great quality of life The region offers a combination of vibrant cities and villages with a wide range of recreational opportunities. Utrecht is developing the concept of Healthy Urban Living, using smart technology to improve wellbeing and health. The Utrecht Region offers special facilities for expats, including one-stop permit and immigration services and a choice of international schools. And what is more, the Utrecht Region has been ranked the most competitive place on the European mainland by the European Commission since 2010. 2

Utrecht has an excellent ecosystem for life sciences and health companies The combination of top-ranked academic institutions, a wide range of locations and great support networks will help you put your company on the map. Skills The range of academic disciplines concentrated at the Utrecht Science Park is unprecedented in Europe. Our life sciences and health community includes 1,700 researchers, 1,750 PhD candidates, more than 2,000 master and bachelor students and 3,500 international summer school students. Corporate Facilities Utrecht offers a wide variety of corporate locations, ranging from corporate office facilities at the city center to state-ofthe-art laboratory facilities at the Utrecht Science Park for innovative life sciences and health companies. Utrecht Science Park is the biggest of its kind in the Netherlands, a 322 hectare research, education and business campus offering top-level facilities for companies wishing to set up or expand in the region. Support initiatives and sector organisations By locating in Utrecht Region, your life sciences company will benefit from the wide range of alliances and joint initiatives involving scientific institutions, local government and companies. 3

Utrecht Life Sciences (ULS) is an innovation network that facilitates strategic partnerships in education, research and entrepreneurship between academia, public institutions and private organisations. The aim of the network is to drive innovations in human and veterinary healthcare by providing state of the art shared infrastructures, scouting and educating talented people, creating access to scarce expertise and databases, and increasing access to external grants and funds. Immuno Valley is a national network of 30 companies and knowledge institutions working together in the field of human and animal health. It aims to jointly develop techniques to diagnose, prevent and treat infectious diseases. Pontes Medical is a public private alliance focused on the development of new medical instruments, bridging the gap between specialists, researchers, health care providers, businesses and investors to develop and test new products and bring them to market. There are also several province-wide initiatives to help fledgling entrepreneurs. UtrechtInc is an incubator and support organisation for innovative entrepreneurs and has supported over 150 startups since 2009, some through private pre-seed funding. Moreover, the UMC Utrecht is founding partner of the Dutch- Flemish MBI LS&H programme and the global Eureka Institute for Translational Medicine. The Invest Utrecht organisation offers free-ofcharge practical assistance and information services to foreign life sciences and health companies venturing into the Utrecht region. Regional financing initiatives Companies can benefit from the various regional co-financing initiatives which are available for the life sciences and health industry within the region. For example, Economic Board Utrecht has launched a scheme to support R&D projects which involve an alliance with local scientific institutes or companies. To qualify, a company must be established in the Utrecht region and contribute at least 30% of total project costs. Companies based in the Utrecht Region can also apply for assistance from additional national EU funding initiatives. Companies can benefit from regional co-financing initiatives Several national and EU funding options are available 4

Inspiring companies and partners for collaboration The Utrecht Region is home to dozens of innovative private companies creating strategic partnering options and facility sharing, and the focus on life sciences and health is spread across the province. The presence of so many top-rated institutes and life sciences companies has stimulated the development of a strong network of private and public sector enterprises. Micreos Human Health develops targeted antibacterial products for human health while Bilthoven Biologicals is part of the Serum Institute of India, the biggest vaccine manufacturer in the world. Intravacc is a notfor-profit R&D institute focusing on improving vaccines, vaccine processes and vaccine technologies. AM-Pharma is a biopharmaceutical company developing proprietary therapeutics to treat chronic or life-threatening inflammatory diseases. Pfizer Inc has a minority equity interest. These are just some of the many international and domestic life sciences and health companies which have made the Utrecht Region their home. Take, for example, Danone Nutricia Research which carries out R&D for early life nutrition and advanced medical nutrition, combining research into food technology and human health. Or what about Genmab, the largest biotechnology company in Europe, that specializes in the creation and development of differentiated antibody therapeutics for the treatment of cancer through immunotherapy. Meanwhile Merus is a clinical-stage immunooncology company developing innovative bispecific antibody therapeutics. 5

Education, talent and knowledge 46% of the workforce has an academic degree 8 mln skilled employees within an hour s travel of Utrecht The Utrecht life sciences and health industry benefits from the region s well-educated, multilingual working population. Some 46% of the workforce has an academic degree and there are 8 milion skilled employees within an hour s travel of Utrecht. Utrecht University is consistently ranked as one of the best in the Netherlands and is home to one of the world s top-rated faculties of veterinary medicine. Utrecht Science Park hosts the Princess Máxima Center for pediatric oncology which has a particular focus on preventing the development of negative side effects of treatment in young patients. The Hubrecht Institute, part of the Royal Dutch Academy of Sciences, carries out groundbreaking research into developmental biology and stem cells. The Westerdijk Fungal Biodiversity Institute, also part of the Royal Dutch Academy of Sciences, holds the largest collection of living fungi in the world and works on the taxonomy and evolution of fungi as well as on functional aspects of fungal biology and ecology. In terms of support staff, the HU University of Applied Sciences Utrecht offers degree courses in life sciences laboratory research and pharmacology. The region is also home to a number of research institutes, including the Netherlands Institute for Public Health and the Environment (RIVM) in Utrecht. The Netherlands Organisation for Applied Scientific Research (TNO) has based its institute focusing on food, health and innovative food technology in nearby Zeist. Several Utrecht Region life sciences companies and institutes, including the Hubrecht Institute and Genmab, are involved in the new Institute for Human Organ and Disease Model Technologies, which is working on innovative ways to develop human organ and disease models on microchips. For more information, please contact: Mr. Jan Zuidema - Head of Invest Utrecht www.investutrecht.com jan@investutrecht.com +31 6 2112 4552 6

Testimonials: companies who were here before you Karl Rothweiler co-founder at Aglaia BioMedical Ventures Utrecht is the home base for a unique selection of top-notch research institutes together with a growing number of successful life science companies. Add to this the central location and great environment for working and relaxing and you ll see why Utrecht offers truly fertile ground for starting and expanding your life science business. Jan Koedam director Early Development at Celgene B.V At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. The city s central location in the Netherlands was pivotal in our decision to establish the Dutch branch of Celgene in Utrecht. We have business activities throughout the country and it is easy to reach them all. We are also close to many relevant institutions, such as University Medical Center Utrecht. Edwin Ket director at Bristol-Myers Squibb Four years ago, BMS decided to move to the city of Utrecht because of its central location within the Netherlands. Here, we are within easy travelling distance of our clients. Perhaps even more important is the fact that Utrecht is home to many healthcare-related bodies, such as patient organisations, the Dutch Healthcare Authority and the umbrella groups representing hospitals, healthcare insurers and medical professionals. The number and the quality of life science organisations, businesses and scientific institutions already located in Utrecht is a positive surprise. We very much support Utrecht s ambition to develop a life sciences ecosystem. Remco Brandt managing director at Bioceros Bioceros is one of Europe s premier providers of GMP-ready protein producing cell lines. The funding provided by the Utrecht Region to startups bringing innovative services or products to the market was a key reason for our decision to locate here. Despite some problems with accessibility and parking, we have stayed in Utrecht because additional laboratory space came available. We also appreciate being close toutrecht University and Utrecht University of Applied Sciences. The labour market is tight and having the universities on our doorstep enables us to expand our workforce easily. We started out with six employees but are now hiring employees 32 and 33. Jan van de Winkel CEO at Genmab Utrecht is an excellent location for biotech companies to establish their businesses. The area provides an exceptional innovation ecosystem thanks to the combination of a highly educated workforce, a world-class university, outstanding hospitals and renowned life sciences research institutes. Utrecht is centrally located in the Netherlands and provides an inspirational environment to work, live and relax in. 7